Opportunities this week:

Cairn last week provided an upbeat trading statement for its first half of the year, we retain our Overweight rating on the stock and our target price to €2.41 (c. 11% upside).
Following a busy week of low-key announcements and given uncertainties in the pharmaceuticals sector, we are revising our price target on GSK from 2010p to 1820p.
Last week Kingspan shares traded slightly higher to €71.95 (+1.48%) despite negative market news related to the Grenfell Tower Investigation. We reiterate our overweight recommendation and target price of €88.00.